Establishment of nomogram prediction model for patients with chronic obstructive pulmonary disease based on Lasso feature screening
- PMID: 40453046
- PMCID: PMC12123110
- DOI: 10.1177/20552076251346674
Establishment of nomogram prediction model for patients with chronic obstructive pulmonary disease based on Lasso feature screening
Abstract
Background and objective: To establish a nomogram prediction model for patients with chronic obstructive pulmonary disease (COPD) based on Lasso feature screening using acoustic features and general clinical data, as well as a risk warning model for patients with acute exacerbation of COPD (AECOPD), and to investigate the performance and value of these two models.
Methods: A total of 240 male COPD patients, including 41 patients with acute exacerbation, and 82 healthy control male volunteers were enrolled as subjects from October 2022 to January 2024. Acoustic features and general clinical data were collected. Lasso regression was used to screen variables related to COPD and AECOPD diagnosis, and nomogram models were separately established and verified by the receiver operating characteristic (ROC) curve, calibration curve, and decision curve.
Results: Variables related to COPD diagnosis screened by Lasso regression included age, smoking history, a_Jitter, e_MFCC1, e_F2 frequency, i_H1-A3, i_F1 amplitude, o_F1 amplitude, and u_MFCC4, and the variables related to AECOPD included expectoration, mMRC grade, i_Jitter, i_F2 frequency, i_Alpha Ratio, and u_H1-H2. The ROC Curve showed that the Area Under the Curve (AUC) of the COPD nomogram model was 0.95, and the AUC of the AECOPD risk warning model was 0.83. The calibration curve indicated that nomogram models showed reasonable consistency, and the Mean Absolute Error (MAE) values were 0.026 and 0.028, respectively. The decision curve indicated that nomogram models showed good benefit, and the benefit thresholds were nearly full threshold, and 0.11-81 and 0.88-0.99, respectively.
Conclusion: The nomogram models for COPD prediction and risk warning of AECOPD can be used as a clinical auxiliary diagnostic and early screening method, providing new insights into the intelligent auscultation of COPD.
Keywords: Chronic obstructive pulmonary disease; Lasso; acoustic feature; auscultation; nomogram model.
© The Author(s) 2025.
Conflict of interest statement
The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.
Figures












Similar articles
-
Construction and validation of nomogram prediction model for risk of acute heart failure in patients with acute exacerbation of chronic obstructive pulmonary disease.Medicine (Baltimore). 2024 Jan 5;103(1):e36840. doi: 10.1097/MD.0000000000036840. Medicine (Baltimore). 2024. PMID: 38181256 Free PMC article.
-
[Establishment and verification of risk prediction model of acute exacerbation of chronic obstructive pulmonary disease based on regression analysis].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Jan;33(1):64-68. doi: 10.3760/cma.j.cn121430-20200720-00534. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 33565403 Chinese.
-
Analysis of risk factors and development of predictive model for acute myocardial injury in patients with acute exacerbation of chronic obstructive pulmonary disease.J Thorac Dis. 2025 Apr 30;17(4):1977-1990. doi: 10.21037/jtd-2024-1992. Epub 2025 Apr 27. J Thorac Dis. 2025. PMID: 40400939 Free PMC article.
-
Construction and validation of risk prediction model for deep vein thrombosis in acute exacerbations of chronic obstructive pulmonary disease based on serum angiopoietin 2 levels.Ann Palliat Med. 2021 Jul;10(7):7905-7918. doi: 10.21037/apm-21-1448. Ann Palliat Med. 2021. PMID: 34353078
-
Development and validation of a nomogram for assessing survival in acute exacerbation of chronic obstructive pulmonary disease patients.BMC Pulm Med. 2024 Jun 19;24(1):287. doi: 10.1186/s12890-024-03091-w. BMC Pulm Med. 2024. PMID: 38898420 Free PMC article.
References
-
- Chronic Obstructive Pulmonary Disease Group of Chinese Thoracic Society. Chronic Obstructive Pulmonary Disease Committee of Chinese Association of Chest Physician. Guidelines for the diagnosis and management of chronic obstructive pulmonary disease (revised version 2021). Chin J Tuberculosis Resp Dis 2021; 44: 170–205. - PubMed
-
- Wang C, Xu JY, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet 2018; 391: 1706–1717. - PubMed
-
- Sha JJ, Lu Z, Jiang T, et al. Research progress in informatization of four-methods diagnosis for chronic obstructive pulmonary disease. Chin J Inf 2023; 30: 186–190.
-
- Expert group on management of acute exacerbation of chronic obstructive pulmonary disease. Expert consensus on the acute exacerbation of chronic obstructive pulmonary disease in China (revision in 2023). Int J Resp 2023; 43: 132–149.
-
- Deng TT, Chen Q, Guo ZQ, et al. Diagnostics in Chinese medicine. Shanghai: Shanghai Science and Technology Press, 1984, p. 41.
LinkOut - more resources
Full Text Sources
Miscellaneous